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Activated CREB Is Sufficient to Overcome
Inhibitors in Myelin and Promote
Spinal Axon Regeneration In Vivo
associated glycoprotein (MAG), and oligodendrocyte-
myelin glycoprotein (OMgp) (Filbin, 2003). Interestingly,
MAG and OMgp, as well as at least one inhibitory domain
of Nogo, interact with the same receptor complex to
exert their inhibitory effect, suggesting redundancy
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among the inhibitors. This receptor complex consistsHunter College
of a GPI-linked protein named Nogo receptor (NgR) be-City University of New York
cause it was originally identified as a binding partner695 Park Avenue
for a 66 amino acid sequence of Nogo, predicted to beNew York, New York 10021
extracellular (Domeniconi et al., 2002; Fournier et al.,2 Howard Hughes Medical Institute
2001; Liu et al., 2002; Wang et al., 2002b). The transduc-3 Center for Neurobiology and Behavior
ing component of this receptor complex was identifiedCollege of Physicians and Surgeons
as the neurotrophin p75 receptor (p75NTR) (Wang et al.,of Columbia University
2002a; Wong et al., 2002). Recently, a third component1051 Riverside Drive
of this receptor complex has been described—a trans-New York, New York 10032
membrane protein called Lingo (Mi et al., 2004). As these
three inhibitors all interact with at least one common
receptor complex, the signal transduction pathway thatSummary
results in inhibition of axonal growth must also be shared
by all inhibitors. It follows, then, that activation of aInhibitors in myelin play a major role in preventing
parallel pathway that blocks the signaling of one inhibi-spontaneous axonal regeneration after CNS injury. El-
tor would do the same for all three inhibitors.evation of cAMP overcomes this inhibition, in a tran-
Previously, we (Cai et al., 1999) and others (Song etscription-dependent manner, through the upregula-
al., 1998) found that when cAMP is elevated, either withtion of Arginase I (Arg I) and increased synthesis of
analogs or by priming neurons with a variety of neuro-polyamines. Here, we show that the cAMP effect re-
trophins, inhibition and repulsion by both MAG and byquires activation of the transcription factor cAMP re-
myelin in general are overcome. Importantly, elevationsponse element binding protein (CREB) to overcome
of cAMP by direct injection of db-cAMP into the cellmyelin inhibitors; a dominant-negative CREB abol-
body of dorsal root ganglion (DRG) neurons is sufficientishes the effect, and neurons expressing a constitu-
to induce regeneration of subsequently lesioned spinaltively active form of CREB are not inhibited. Activation
axons that emit from the same cell body as was injectedof CREB is also required for cAMP to upregulate Arg
(Neumann et al., 2002; Qiu et al., 2002). Without elevationI, and the ability of constitutively active CREB to over-
of cAMP, these axons, like all spinal cord axons, failcome inhibition is blocked by an inhibitor of polyamine
to regenerate. The question then becomes how cAMPsynthesis. Finally, expression of constitutively active
induces axons to grow through an inhibitory environ-CREB in DRG neurons is sufficient to promote regen-
ment. We showed that both the db-cAMP and neuro-eration of subsequently lesioned dorsal column axons.
trophin effect in overcoming inhibition are each tran-These results indicate that CREB plays a central role
scription dependent. One gene that is upregulated inin overcoming myelin inhibitors and so encourages
response to either treatment is for the enzyme Arginaseregeneration in vivo.
I (Arg I), a key enzyme in the synthesis of polyamines.
Indeed, overexpressing Arg I or addition of the poly-
Introduction
amine putrescine to neurons in culture is each sufficient
to overcome inhibition by MAG and myelin (Cai et al.,
The lack of CNS regeneration in adult mammals is largely 2002). The steps between elevation of cAMP (activation
attributable to the presence of an inhibitory environ- of PKA) and upregulation of Arg I and polyamines are
ment. In general, there have been two approaches to not known.
encourage regeneration in vivo—change the environ- In many other situations, activation of the transcription
ment by blocking/neutralizing inhibitors of regeneration factor cAMP response element binding protein (CREB)
(Bradbury et al., 2002; Bregman et al., 1995; GrandPre is a requirement not only for upregulation of a variety
et al., 2002), or change the intrinsic growth state of of genes in response to elevated cAMP, but also in
the neuron/axon such that it no longer responds to an response to a variety of signal transduction pathways,
inhibitory environment (Lehmann et al., 1999; Neumann not necessarily involving cAMP (Lonze and Ginty, 2002).
et al., 2002; Qiu et al., 2002). In an injured CNS, an To date, at least six CREB-like molecules have been
axon that attempts regeneration faces both inhibitors of identified, and they act by forming homo- or heterodim-
regeneration in myelin and a physical barrier presented ers, before binding to CRE sequences to regulate tran-
by a glial scar (Filbin, 2003; Schwab and Bartholdi, 1996; scription (Mayr and Montminy, 2001; Montminy, 1997;
Silver and Miller, 2004). To date, three inhibitors of re- Shaywitz and Greenberg, 1999). More than 100 genes
generation have been identified in myelin-Nogo, myelin- have been reported to be upregulated following activa-
tion of either CREB or a closely related protein (Lonze
and Ginty, 2002). Of these, different repertoires of gene*Correspondence: filbin@genectr.hunter.cuny.edu
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expression have been implicated in different neuronal
processes such as survival, synaptic plasticity, memory
and learning, and drug habituation and addiction (Kan-
del, 2001; Lonze and Ginty, 2002; Nestler, 2001; Silva
et al., 1998). Here, we show that activation of CREB,
or a CREB-like molecule, is also required to overcome
inhibition by MAG and myelin in response to either db-
cAMP or the neurotrophin brain-derived neurotrophin
factor (BDNF). Activation of CREB, alone, is sufficient
to overcome inhibition by myelin and to promote spinal
axon regeneration in vivo. Furthermore, activation of
CREB is required for either db-cAMP or BDNF to upregu-
late Arg I. These results not only help us expand our
understanding of the signaling pathway that allows
cAMP to overcome inhibition by MAG and myelin and
encourage regeneration in vivo, but they also reveal yet
another system in which CREB activation appears to be
essential, in this case axonal regeneration in an inhibi-
tory environment.
Results
Figure 1. Activation of CREB in Response to BDNF and db-cAMP
Cerebellar neurons were plated on poly-l-lysine in the presence or
Dominant-Negative CREB Blocks the Ability absence of either BDNF (200 ng/ml) (A) or db-cAMP (1 mM), with
of BDNF and db-cAMP to Overcome and without the PKA inhibitor H89 (5 mM), and for various times as
Inhibition by MAG indicated (B) before being lysed, subjected to Western blotting, and
stained for phospho-CREB (P-CREB). The blots were stripped andIt has been established that the strength and the dura-
stained for total CREB. Similar results were obtained from at leasttion of activation of CREB varies depending on the extra-
three experiments.cellular stimulus and/or the signaling pathway that in-
duces the activation (Lonze and Ginty, 2002). This in
turn has been implicated in influencing what CREB-
also positive for the neuronal marker GAP43. By onlydependent genes are transcribed. Because we observe
measuring neurites from neurons positive for both GFPdifferences in the timing and also in the strength of the
and GAP43, we ensured that only infected neurons weresignal resulting from treatment with BDNF and db-cAMP
included in the analysis. Figures 2B and 2C show, asin overcoming inhibition by MAG and myelin, we first
we reported before, that for cerebellar and DRG neuronswanted to compare the time course and the extent of
MAG inhibits neurite outgrowth by about 70% and 40%,activation of CREB in response to these two stimuli.
respectively, regardless of whether they are infectedTo do this, cerebellar neurons were plated onto poly-l-
with any of the viral constructs (Cai et al., 1999; Mukho-lysine and incubated in the presence or absence of
padhyay et al., 1994). Furthermore, the percent inhibitionBDNF or db-cAMP for various times before being lysed
relative to control was the same regardless of whetherand activation determined by assessing levels of Ser133-
we measured the longest neurite from each neuron orphosphorylated-CREB (phospho-CREB) by Western blot-
the total process length (data not shown). In sharp con-ting. As shown before, both BDNF and db-cAMP induce
trast, unlike uninfected or control-infected neurons,activation of CREB. For BDNF, the peak of activation is
where db-cAMP blocks inhibition, it has no effect onbetween 15 and 30 min, and by 120 min activated CREB
inhibition by MAG of neurons expressing A-CREB. In ahas returned to control levels. In contrast, for neurons
similar manner, the ability of priming with either BDNFtreated with db-cAMP, by 5 min phospho-CREB is ap-
or NGF to overcome inhibition is blocked by expressionparent, with activation peaking at about 60 min, but it
of A-CREB (Figure 2D). This is not a general effect onis still strong at 120 min. Therefore, db-cAMP activates
growth, as neurons expressing A-CREB are unaffectedCREB by phosphorylation of Ser133 more robustly and
in their ability to extend long neurites on control CHOfor longer than BDNF (Figure 1).
cells not expressing MAG. In other controls, infectionTo determine if activation of CREB is required to over-
with WT-CREB-containing virus or control virus has nocome inhibition by MAG by either priming with BDNF
effect on the ability of neurotrophins or db-cAMP toor addition of db-cAMP, a dominant-negative CREB,
overcome inhibition by MAG (Figures 2B–2D). In addi-A-CREB, was used. We first confirmed that in our hands
tion, under the conditions used here, as assessed byA-CREB was indeed behaving in a dominant-negative
comparing the number of live and dead cells under thefashion using a reporter gene system (data not shown).
various conditions, using probes that measure two rec-To assess the effect of A-CREB on neurite outgrowth,
ognized parameters of cell viability, calcein AM (liveboth cerebellar and DRG neurons were infected with
cells) and ethidium homodimer (dead cells) uptake, itthe A-CREB-containing, wild-type CREB-containing, or
was clear that expression of A-CREB has no effect oncontrol adenoviruses before being plated onto mono-
neuronal survival, regardless of the substrate usedlayers of MAG-expressing Chinese hamster ovary (CHO)
(Supplemental Figure S1 at http://www.neuron.org/cgi/cells or control CHO cells. Figure 2A shows a typical
infected cerebellar neuron, expressing GFP, which is content/full/44/4/609/DC1/).
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Figure 2. Dominant-Negative CREB Blocks
the Ability of db-cAMP and BDNF to Over-
come Inhibition by MAG
(A) A typical infected cerebellar neuron ex-
pressing GFP (left) and GAP43 (right).
(B)–(D) Cerebellar (P5–P7) or DRG (P5–P7)
neurons were isolated and infected with ei-
ther control Ad virus or A-CREB containing
Ad virus and primed overnight with either
BDNF or NGF (200 ng/ml) (D) before being
transferred to either MAG-expressing (striped
bars) or control CHO (white bars) cells, or db-
cAMP was added directly to the cocultures
(B and C). After overnight coculture, neurons
were fixed and stained for GAP43 and viewed
for GFP. In each experiment, the mean length
of the longest GAP43-positive neurite for 180
to 200 neurons was measured (SEM), for at
least three separate experiments.
Neurons Expressing Constitutively Active CREB rons that were both GFP and GAP43 positive. Figure 3C
shows that DRG neurons that express VP16-CREB areAre Not Inhibited by MAG
To address whether activation of CREB alone is suffi- not inhibited by MAG, while control-infected neurons
are inhibited to the same extent as we routinely findcient to overcome inhibition by MAG, a constitutively
active form of CREB, VP16-CREB, was used (Barco et for uninfected neurons, by about 40%. These results
suggest that activation of CREB is sufficient to changeal., 2002). The VP16-CREB chimeric cDNA was inserted
into an adenovirus delivery vector that also contained the neuron’s response to MAG such that it is no
longer inhibited.the GFP cDNA. The expression of the transgene is regu-
lated by the tTA/tetO system such that expression of
the transgene is obtained only after coinfection with Neurons from a Transgenic Mouse Expressing
Constitutively Active CREB Are NottTA-expressing adenovirus and in the absence of Dox.
Figure 3A shows typical infected DRG neurons positive Inhibited by MAG and Myelin
Using this same constitutively active VP16-CREB andfor GFP and the neuronal marker GAP43. Expression of
the VP16-CREB protein in the infected neurons was the same Tet-regulatory system, a transgenic mouse
was made, in which the expression of the transgene isconfirmed by Western blotting, and Figure 3B shows
that coinfection with the tTA-expressing adenovirus, in under the control of the CaMK II promoter (Barco et
al., 2002). Expression of VP16-CREB was turned on bythe absence of Dox, significantly increases VP16-CREB
expression. Neurons infected with virus with or without removal of Dox from the diet in mice 3 weeks old for 1
week before we started our experiments. However,the VP16-CREB were then cultured on either MAG-
expressing or control CHO cells, in the absence of Dox. these mice do not express the transgene in the neuronal
types that we routinely use in our neurite outgrowthAgain to ensure that only infected neurons were as-
sessed, neurites were measured only from those neu- experiments, DRG and cerebellar neurons (Figure 4A
Neuron
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Figure 3. Expression of Constitutively Active
CREB Is Sufficient to Block Inhibition by MAG
DRG neurons (P5–P7) were dissociated and
infected with adenovirus vectors containing
the cDNA for VP16-CREB and GFP or with
the cDNA for GFP only. Twenty-four hours
after infection, the neurons were either lysed
and subjected to Western blotting or trans-
ferred to MAG-expressing CHO cells, control
CHO cells, or myelin, before being fixed and
stained for GAP43 and viewed for GFP. (A)
Image of control-infected (left panel) and
VP16-CREB-infected (right panel) neurons
positive for both GFP and GAP43. (B) Western
blot of neurons infected with VP16-CREB
cDNA-containing virus or with control virus,
grown with or without Dox (Tet-off) and
stained for CREB. Arrows indicate the posi-
tions of VP16-CREB and wild-type CREB.
Blots were stripped and immunostained for
actin (bottom panel). (C) Measurement of
neurite length from neurons infected with
control virus (control) or with virus containing
VP16-CREB cDNA (VP16-CREB), grown on
either MAG-expressing CHO cells (striped
bars) or control CHO cells (white bars), before
being fixed and stained for GAP43. In each
experiment, the mean length of the longest
GAP43/GFP-positive neurite for 180 to 200
neurons was measured (SEM). Each experi-
ment was carried out at least three times.
and data not shown). Instead, we used hippocampal outgrowth; neurite length is the same on MAG-express-
ing and on control CHO cells. Likewise, these hippocam-neurons from 1-month-old mice. Figure 4A shows that
there is robust expression of the VP16-CREB transgene pal neurons expressing the VP16-CREB transgene are
not inhibited by myelin (Figure 4B). In contrast, whenin hippocampal neurons, but no expression in DRG neu-
rons, in mice 1 month old and 4 months old that were the same transgenic mice are maintained on Dox and
the VP16-CREB is not expressed, MAG inhibits neuritenot fed Dox. Hippocampal neurons from 1-month-old
mice were then used in the neurite outgrowth assay. outgrowth by about 60%, and relative to growth on poly-
l-lysine, myelin inhibits neurite outgrowth by about 70%Figure 4C shows that for neurons from transgenic mice
expressing VP16-CREB, MAG has no effect on neurite (Figures 4B and 4C). Therefore, consistent with what we
Figure 4. Neurons from a Transgenic Mouse
Expressing Constitutively Active CREB Are
Not Inhibited by MAG
Hippocampal or DRG neurons were removed
from either 1-month-old or 4-month-old
VP16-CREB transgenic (Tg) or wild-type (WT)
mice and either lysed and subjected to West-
ern blotting or transferred to MAG-express-
ing, control CHO cells or myelin as a substrate
and cultured overnight before being fixed and
stained for GAP43. (A) Western blot of lysates
from hippocampal (HN) and DRG neurons
from 1-month-old and 4-month-old trans-
genic mice, stained for CREB. Both VP16-
CREB and WT-CREB are indicated. (B and
C) Measurement of neurite outgrowth from
hippocampal neurons from 1-month-old
VP16-CREB transgenic (Tg) and wild-type
mice, grown on (B) poly-l-lysine (stippled
bars) or myelin (black bars) or (C) MAG-
expressing CHO cells (striped bars) or control
CHO cells (white bars). In each experiment,
the mean length of the longest GAP43/GFP-
positive neurite for 180 to 200 neurons was
measured (SEM). Each experiment was car-
ried out at least three times.
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Figure 5. Expression of Arg I Is Regulated by
CREB, and the Ability of Constitutively Active
CREB to Overcome Inhibition Is Dependent
on Polyamine Synthesis
(A and B) DRG neurons (P5–P7) were infected
with adenovirus containing A-CREB, VP16-
CREB, or only GFP. (A) Uninfected neurons
(), infected with only GFP (GFP) or with
A-CREB, were incubated with 1 mM db-
cAMP (db) or 200 ng/ml BDNF (NT) overnight
before being lysed, or neurons infected with
VP16-CREB (B) were lysed and subjected to
Western blotting and stained for Arg I. Num-
bers at the bottom of each gel refer to the
fold increase relative to control and standard-
ized for loading to actin. (C and D) Measure-
ment of neurite length from control-infected
or VP16-CREB-infected DRG neurons, grown
on (C) myelin or (D) control CHO cells (white
bars) or MAG-expressing CHO cells (striped
bars), with and without DFMO (5 mM) as indi-
cated. In each experiment, the mean length
of the longest GAP43/GFP-positive neurite
for 180 to 200 neurons was measured
(SEM). Each experiment was carried out at
least three times.
observed for neurons infected to express VP16-CREB the increase in Arg I expression is lost completely for
BDNF treatment and more than halved in neuronsin culture, expression of constitutively active CREB
in vivo is sufficient to block inhibition by MAG and myelin treated with db-cAMP (Figure 5A). These results show
that dominant-negative CREB blocks expression of onewhen these neurons are placed in culture. We do not
know, however, if VP16-CREB is preferentially affecting of the proteins that we have shown to be an effector
of cAMP in overcoming inhibition of neurite outgrowthdendritic or axonal growth, as the hippocampal neurons
are not in culture long enough to make the distinction. by MAG.
To complement these observations with dominant-Even after 3 days in culture, under the conditions that
were used here for hippocampal neurons from P30 mice negative CREB, we next asked if Arg I was upregulated
in neurons infected with constitutively active VP16-all processes are positive for both MAP 2, a dendritic
marker, and  III tubulin, a general neuronal marker, CREB. Figure 5B is a Western blot for Arg I and shows
that, in neurons infected with virus containing VP16-regardless of whether CREB is activated (data not
shown; Dotti et al., 1988). CREB, expression of Arg I has more than doubled. Re-
sults are standardized to a protein that does not change
expression in the presence of VP16-CREB. This sug-CREB Regulates the Expression of Arginase I
gests that activation of CREB is sufficient to induce anto Overcome Inhibition
upregulation in expression of Arg I, but is this what isPreviously, we reported that upregulation of Arg I, a key
responsible for activated CREB’s ability to overcomeenzyme in the synthesis of polyamines, by either db-
inhibition by MAG? To address this question, we in-cAMP or priming with BDNF is sufficient to overcome
cluded in the neurite outgrowth assay an inhibitor ofinhibition by MAG and myelin. We also showed that
the Arg I-dependent polyamine synthesis pathway. Theblocking the polyamine pathway blocked the ability of
agent, DFMO, is an inhibitor of the enzyme followingupregulated Arg I to overcome inhibition and that exoge-
Arg I in the pathway, ornithine decarboxylase (ODC).nous polyamines, alone, could block inhibition (Cai et
Previously, we showed that DFMO blocked the abilityal., 2002). To determine if the increase in Arg I expression
of db-cAMP and priming with BDNF to overcome inhibi-is dependent on activation of CREB, neurons expressing
tion by MAG. Figures 5C and 5D show that the abilityA-CREB were treated with either BDNF or db-cAMP,
of neurons expressing VP16-CREB to grow on MAG orand then Western blots of the cell lysates were immuno-
myelin was blocked when DFMO was included in thestained for Arg I. Here, we demonstrate that A-CREB
cultures, suggesting that indeed it is the upregulationblocks the upregulation of expression of Arg I in re-
of Arg I and synthesis of polyamines by constitutivelysponse to either db-cAMP or BDNF. Figure 5A shows
active CREB that overcomes inhibition by MAG.a Western blot of lysates from uninfected, control-
infected, and A-CREB-infected DRG neurons immuno-
stained for Arg I protein. We reported before that High Levels of Activated CREB Are Required
to Overcome Inhibition by MAGdb-cAMP and BDNF induce a 6- to 7-fold increase and
2- to 3-fold increase in Arg I expression, respectively. Neurotrophin Trk receptors, and not p75NTR, are re-
quired for the priming effect to overcome inhibition (GaoNow, we show that this holds true for both uninfected
and control-infected neurons (Figure 5A). However, et al., 2003). Upon interaction with Trk receptors, neuro-
trophins such as BDNF can activate a number of differ-when infected with a virus containing A-CREB cDNA,
Neuron
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BDNF’s activation of CREB each block completely the
ability of BDNF to overcome inhibition by MAG. We en-
sured the specificity of the inhibitors by showing that
neither the PI3K nor the CaMK inhibitors had any effect
on the phosphorylation of Erk by BDNF (Supplemental
Figure S2 at http://www.neuron.org/cgi/content/full/44/
4/609/DC1/). None of these inhibitors affected neurite
outgrowth on control CHO cells that did not express
MAG, neither when they were included during priming
with BDNF nor when they were added directly to the
cocultures along with db-cAMP. This indicates that, al-
though growth induced on the control CHO cells may
involve activation of these pathways, simultaneous acti-
vation of all these pathways is not essential for this
neurite outgrowth.
Previously, we showed that, at a concentration of
1 mM db-cAMP, activation of the Mek/Erk pathway as
well as the PKA pathway is required to overcome inhibi-
tion, while at 2 mM db-cAMP only activation of PKA is
required (Gao et al., 2003). Figure 7A shows that this is
also true for db-cAMP-induced activation of CREB. At
1 mM db-cAMP, activation of CREB is reduced, and the
ability to overcome inhibition is blocked by either a PKA
or a Mek/Erk inhibitor but not by inhibitors of PI3K or
CaMK (Figures 7A and 7B). However, at 2 mM db-cAMP,Figure 6. Activation of at Least Four Pathways by BDNF Is Required
to Reach the Level of Activation of CREB Necessary to Overcome a Mek/Erk inhibitor has no effect on the phosphorylation
Inhibition by MAG of CREB (Figure 7C) or on its ability to overcome inhibi-
Cerebellar neurons (P5) were dissociated and primed for 30 min (A) tion (Gao et al., 2003). Together, these results suggest
or overnight (B), with and without BDNF (200 ng/ml), in the presence that a relatively high level of activated CREB is required
or absence of each of the following inhibitors: PKA inhibitor (200 to overcome inhibition by MAG. For priming with BDNF,
nM KT5720), PI3K inhibitor (20 M LY294002), MEK inhibitor (5 M
the level is reached by activation of four pathways simul-U0126), or CaMK inhibitor (10 M KN62) as indicated, before being
taneously. For lower concentrations of db-cAMP (1 mM),lysed and subjected to Western blotting or transferred to either
activation of both PKA and Mek/Erk pathways are re-MAG-expressing CHO cells or control CHO cells. (A) Western blot
stained for phospho-CREB (P-CREB) and then stripped and stained quired, while at higher db-cAMP (2 mM), activation of
for CREB. (B) Measurement of neurite length from neurons grown the PKA pathway is strong enough alone to reach the
on MAG-CHO cells (striped bars) or on control CHO cells (white requirement of CREB activation to overcome inhibition.
bars) overnight before being fixed and stained for GAP43. In each
experiment, the mean length of the longest neurite for 180 to 200
Myelin Attenuates the Activation of CREBneurons was measured (SEM). Each experiment was carried out
at least three times. by BDNF but Not by db-cAMP to below
the Level Required to Overcome Inhibition by MAG
Previously, we showed that to overcome inhibition neu-
rons needed to be exposed to neurotrophins before theyent signaling cascades, each of which results in activa-
tion of CREB and transcription of a variety of genes encountered the inhibitor. In contrast, prior exposure of
the neuron to db-cAMP was not required to overcome(Kaplan and Miller, 2000). To determine which of these
signaling pathways is required for the priming effect of inhibition (Cai et al., 1999). Our working hypothesis is
that MAG and myelin activate a heterotrimeric G proteinBDNF, the effect of inhibitors of these different pathways
was assessed on both phosphorylation of CREB and Gi/Go, which inhibits adenylate cyclase, the enzyme that
synthesizes cAMP, and so attenuates cAMP accumula-the ability of priming with BDNF to overcome inhibition.
When inhibitors of protein kinase A (H89), PI3K (LY), tion in response to neurotrophin. Therefore, cAMP must
be allowed to accumulate and trigger downstream path-Erk (U0126), or CaM kinase (KN62) were each included
during priming with BDNF, activation of CREB was re- ways before adenylate cyclase is inhibited by interaction
with MAG/myelin. On the other hand, when cAMP isduced in each case but not completely abolished (Figure
6A). This suggests that it is the additive effect of these artificially elevated by addition of db-cAMP, it is inde-
pendent of adenylate cyclase, and so priming is notsignaling cascades that accounts for the final activation
of CREB in response to BDNF. To assess the effect of required. Here, we sought to determine if the ability of
BDNF and db-cAMP to activate CREB is affected bythese various inhibitors on the ability of BDNF to block
inhibition by MAG, cerebellar neurons were primed with the presence of inhibitor, and for this we used myelin.
Cerebellar neurons were cultured on either a substrateBDNF, with and without the inhibitors, before being cul-
tured on MAG-expressing or control CHO cells. Figure of poly-l-lysine or purified myelin, in the presence or
absence of either BDNF or db-cAMP. After 30 min, they6B shows that, when inhibitors of the PKA, PI3K, Erk,
or CaMK pathways are each included during priming, the were fixed and stained for phospho-CREB or subjected
to Western blotting for phospho-CREB. As can be seenability of BDNF to block MAG’s inhibition is completely
abrogated. Therefore, those inhibitors that attenuate in Figure 8, when cerebellar neurons are cultured on
Activated CREB Promotes Spinal Axon Regeneration
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Figure 8. Myelin Reduces the Level of Activation of CREB to Back-
ground for BDNF but Not for db-cAMP
Cerebellar neurons (P5) were dissociated and plated onto either
poly-l-lysine (PLL) or myelin and cultured for 30 min in the presence
or absence of BDNF (200 ng/ml) or db-cAMP (1 mM), as indicated,Figure 7. At High db-cAMP Concentrations, Activation of Only PKA
before being fixed and stained for Phospho-CREB, NF200, and DAPIIs Sufficient to Reach the Level of Activation of CREB Needed to
(A) or lysed, subjected to Western blotting, and stained for phospho-Overcome Inhibition by MAG
CREB and then stripped and stained for CREB. Numbers at theCerebellar neurons (P5) were dissociated and cultured with db-
bottom of (B) refer to the fold increase in phospho-CREB relativecAMP at 1 mM (A) or 1 or 2 mM (C), for 30 min (A and C) in the
to control neurons on PLL without BDNF or db-cAMP, standardizedpresence or absence of the inhibitors as indicated in Figure 6 before
to total CREB.being lysed and subjected to Western blot, or neurons were cultured
overnight on MAG-CHO or control CHO cells in the presence of db-
cAMP and/or inhibitors as indicated. (A and C) Western blots stained
blocks almost completely the BDNF-induced but not thefor phospho-CREB (P-CREB) and stripped and stained for CREB.
Fold increase in (C) refers to increase relative to control, standard- db-cAMP-induced activation of CREB.
ized to total CREB per lane. (B) Measurement of neurite length as
described in Figure 6. Expression of Activated CREB Is Sufficient
to Promote Spinal Axon Regeneration In Vivo
Previously, we and others reported that if db-cAMP is
poly-l-lysine activated CREB is barely detectable, but injected directly into DRG cell bodies, and the dorsal
when BDNF or db-cAMP is added, phospho-CREB is column axons of those same neurons are lesioned either
readily detected. Consistent with what we observed 2 days or 1 week later, there is significant regeneration
from Western staining (Figure 1), the signal for phospho- of these central axons (Neumann et al., 2002; Qiu et al.,
CREB is stronger for neurons treated with db-cAMP 2002). To assess if activation of CREB can achieve the
than for those treated with BDNF. When neurons are same effect, VP16-CREB-containing adenovirus was in-
cultured on myelin, in the absence of stimulus, again jected into L4 DRG, 4 days before the dorsal column
phospho-CREB is barely detectable. However, when axons were lesioned. Figure 9A shows that at 4 days
BDNF is added to neurons on myelin, unlike when it postinjection, a considerable number of DRG neurons
is added to neurons on poly-l-lysine, the increase in are infected, as they are positive for the GFP reporter
phospho-CREB was greatly reduced, while addition of and the neuronal marker -III tubulin. Importantly, these
db-cAMP still induces strong activation of CREB. As a neurons also express the transgene, as they are positive
control, myelin has no effect on the ability of BDNF to for VP16-protein (Figure 9A). Hence, at the time of dorsal
activate Erk (Supplemental Figure S3 at http://www. column lesion, at 4 days postinjection, a proportion of
neuron.org/cgi/content/full/44/4/609/DC1/). There- DRG neurons are expressing constitutively active CREB.
fore, at both the immunocytochemical level and as esti- As a control, DRGs were injected with control adenovi-
rus expressing only the GFP reporter. The animals weremated from Western blotting, the presence of myelin
Neuron
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Figure 9. Expression of Constitutively Active
CREB by DRG Neurons Is Sufficient to Pro-
mote Regeneration of Lesioned Dorsal Col-
umn Axons
The L4 DRG of adult rats was injected with
either VP-16 CREB-containing virus (n  8)
or control virus expressing only GFP (n  5).
Four days later, either the animals were sacri-
ficed and the DRGs were sectioned and
stained for VP-16 and -III tubulin, as well as
monitored for expression of GFP (A), or the
dorsal column was lesioned at T6–T7 (B–D).
Before being sacrificed 28 days later, axons
were transganglionically traced with cholera
toxin B subunit (CTb). Serial 20 m longitudi-
nal sections were stained for CTb and -III
tubulin. (B) and (C) are a VP-16 CREB-treated
animal, and (B) is a magnification of the boxed
area in (C). Arrowheads point to axons that
have almost traversed the lesion site. (D) is a
control animal. The asterisks in (B)–(D) repre-
sent the center of the lesion. (E) and (F) are the
measurements of the distance regenerated
from the caudal side of the lesion, with the
approximate center of the lesion as zero,
such that any value greater than zero indi-
cates regeneration beyond the lesion center
(E). (F) is the distance regenerated by the VP-
16 CREB-treated animals (circles; n  7) and
the control animals (diamonds; n  4). The
two groups are significantly different, with
p  0.05.
left for 4 weeks to allow axonal regeneration to occur. animals was about 600 m, while for the control animals
the average was less than 200 m (Figures 9E and 9F).Four days before sacrifice, the dorsal column axons
were transganglionically traced by back filling with the In the majority of the VP16-CREB animals, axons had
grown into the lesion site and beyond the lesion center,B subunit of cholera toxin (CTb), injected into the sciatic
nerve. Figures 9B and 9C show the lesion site of a typical while only rarely were axons observed in the lesion site
of control animals. At most, the axons in the controlanimal injected with VP-16 CREB-containing adenovi-
rus, and axons that have grown up to and into the lesion animals reached the caudal edge of the penumbra but
never entered the lesion site proper. Furthermore, wesite are clearly visible. A few have almost reached the
rostral boundary of the lesion (Figures 9B and 9C, arrow- also showed that there was no difference in survival/
apoptosis after a dorsal column lesion of neurons in-heads). In sharp contrast, in control animals CTb-traced
axons were only very rarely observed close to the lesion; fected with either the control virus or the VP-16 CREB
virus. Animals were injected with virus into the DRG,in the majority of cases, as is usual, the axons had
retracted from the caudal boundary of the lesion (Figure and 2 days later the dorsal column axons were lesioned.
After a further 2 days, the animals were sacrificed, and9D). When the distance that axons had regenerated from
the caudal edge of the lesion (where the penumbra be- DRGs were assessed for expression of both GFP and
 III tubulin to ensure that only infected neurons weregins) was measured, the average for the VP16-CREB
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being counted, as well as for Tunel staining to identify the expression is relative to what is required to maximize
the effect. Third, a conditioning lesion is most effectivedying cells. Out of 500 neurons observed in each group,
only 38 infected with the VP16-CREB virus and 21 in- if it is performed 1 week prior to the central lesion (Neu-
mann and Woolf, 1999). We do not know when the opti-fected with the control virus appeared to be dying (data
not shown). This indicates that any effect of VP16-CREB mal time is to activate CREB prior to a dorsal column
lesion. Despite all these caveats, we still observe signifi-on regeneration is not an effect on improving survival.
These results indicate that expression of constitutively cant and obvious regrowth of dorsal column axons in
animals expressing VP16-CREB and not in animals in-active CREB is sufficient to promote spinal axon regen-
eration in vivo. jected with the control virus.
The results are intriguing because they also suggest
that a threshold of activation of CREB is required toDiscussion
overcome inhibition. For BDNF, where the cumulative
activation of CREB through at least four pathways isIt has already been established that elevation of cAMP
not as robust or as prolonged as the activation seencan overcome inhibition by MAG and myelin to encour-
with db-cAMP, activation of all four pathways is requiredage spinal axon regeneration in a transcription-depen-
to reach the putative threshold. In contrast, even at 1 mMdent manner (Cai et al., 1999, 2002; Song et al., 1998).
db-cAMP, a strong activation of CREB is observed, andNow, we include activation of CREB, or a closely related
it is sustained for longer than that for the BDNF re-family member, as a necessary step in this signaling
sponse. However, at 1 mM db-cAMP, this strong re-pathway. Our working model is, then, that in response
sponse is a consequence of the combined activation ofto elevated cAMP, CREB is activated, and the enzyme
CREB through the PKA and Mek/Erk pathways; inhibi-Arg I is upregulated, resulting in an increase in polyamine
tors of each of these pathways attenuate the activationsynthesis. Polyamines, in turn, are necessary and suffi-
of CREB by 1 mM db-cAMP and block its ability tocient to overcome inhibition and encourage regenera-
overcome inhibition. By contrast, at 2 mM db-cAMP,tion in vivo (Filbin, 2003). All the results presented here
inhibition of the Mek/Erk pathway has no effect on acti-are consistent with and support our developing model—a
vation of CREB or on blocking inhibition. The effect atdominant-negative CREB blocks the ability of db-cAMP
2 mM db-cAMP is completely dependent on the PKAor BDNF to induce an upregulation of Arg I and to over-
pathway, consistent with what we have reported pre-come inhibition by MAG/myelin; a constitutively active
viously, that cAMP/PKA must reach a threshold of acti-CREB is sufficient to induce upregulation of Arg I and to
vation to overcome inhibition (Gao et al., 2003).overcome inhibition by MAG/myelin, an effect blocked if
It is of note that, although during priming signaling bythe polyamine synthesis pathway is blocked. Impor-
BDNF is required to subsequently overcome inhibitiontantly, expression of activated CREB in DRGs in vivo
by MAG, this same BDNF signaling is not essential foris sufficient to promote regeneration of subsequently
growth when neurons are subsequently grown on con-lesioned dorsal column axons. Identifying activation of
trol CHO cells. This is apparent because if activationCREB as a key step in this process is crucial, because
of either PI3-K or Mek, which has been shown to beit provides an important putative target for therapeutic
necessary for process outgrowth in response to neuro-intervention to enable axonal growth through the hostile
trophins (Liu and Snider, 2001), is blocked during prim-environment of a damaged, adult CNS. Indeed, given
ing with BDNF, it blocks the ability of BDNF to overcomethe central role that CREB appears to play in other sys-
inhibition but has no effect on neurite outgrowth fromtems, it is reasonable to expect that manipulation of
neurons subsequently grown on control CHO cells. ThisCREB’s activity may turn out to be pivotal in encourag-
can be explained as follows. First, BDNF is only presenting regeneration.
during priming, and this priming has no effect on neuriteThe effect of expressing constitutively active CREB
length from neurons subsequently grown on controlin DRG cell bodies mimics the effects of a peripheral
cells in the absence of BDNF. Second, the favorableconditioning lesion on dorsal column regeneration.
environment created by the CHO monolayer accountsMany studies have reported that if the peripheral branch
for the good growth on control CHO cells, which is likelyof DRG neurons is lesioned before the same neurons’
to result in activation of numerous signaling pathways.central branch axons in the dorsal column are lesioned,
This in turn allows for redundancy when any one path-these spinal axons will spontaneously regenerate (Neu-
way, such as PI3-K or Mek, is blocked, therefore growthmann and Woolf, 1999; Richardson and Issa, 1984). We
proceeds.and others have shown this effect to be cAMP depen-
Although we have shown that upregulation of Arg I isdent (Neumann et al., 2002; Qiu et al., 2002). Although
dependent on activation of CREB, we do not know ifsignificant, the regrowth that we observe in response
this effect is direct or indirect. The Arg I promoter regionto expression of activated CREB in DRGs is not as robust
does not appear to contain the consensus, palindromeas the conditioning lesion effect on dorsal column regen-
sequence TGACGTCA, which binds CREB with high af-eration. This is due to a number of reasons. First, only
finity. Rather, it carries a variant CRE half-site, whicha fraction of the DRG neurons are infected with the virus.
can be functional but, because of lower affinity of bind-The animals do not tolerate multiple DRG injections, so
ing, would not be as effective as the full CRE palindromewe were limited in the amount of virus we could deliver
sequence (Craig et al., 2001; Fink et al., 1988; Yamamotoin a single injection to a single DRG. In contrast, lesioning
et al., 1988). If indeed the effect of CREB on Arg I expres-the sciatic nerve conditions all the dorsal column axons
sion is via direct interaction with its promoter, then aemitting from L3, L4, and L5. Second, although we show
expression of the transgene, we do not know how robust half-site rather than a full site may be why a relatively
Neuron
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high level of activated CREB is required to drive expres- state of CREB are also required along with a threshold
sion and overcome inhibition. level of Ser133 to be phosphorylated in order to over-
CREB family members have been shown to be in- come inhibition by MAG and encourage regeneration.
volved in numerous aspects of neuronal function, from Second, there are at least six CREB-like molecules that
survival to learning and memory (Kandel, 2001; Lonze have been identified to date (Lonze and Ginty, 2002).
and Ginty, 2002). How is such a range of effects brought Although the antibody we use to assess activation is
about by activation of this single transcription factor specific for phospho-Ser133 CREB, the dominant-nega-
family? It is possible, as shown here and as proposed tive and constitutively active constructs we use are not
by others, that the strength and/or the duration of CREB (Ahn et al., 1998; Barco et al., 2002). That is to say, the
activation by different stimuli dictate the resulting effect. dominant-negative A-CREB can block the function of a
For example, short, weak activation could result in a number of CREB family members. Likewise, VP16-CREB
survival effect, while a much stronger and longer activa- activity is not confined to CREB but can affect transcrip-
tion is required to overcome inhibitors in myelin. The tional regulation by other family members. The specific-
fact that a differential effect arises from the strength of ity of the antibody we use for phospho-Ser133 CREB
CREB binding is supported by the observation that the lends confidence that the namesake of the family is
effect on survival of neurotrophins, unlike overcoming involved in overcoming inhibition in response to cAMP;
myelin inhibitors, is independent of cAMP/PKA (Boniece it is also highly likely that other family members also
and Wagner, 1993; Rydel and Greene, 1988). The impli- play a role.
cation is that, although neurotrophins do indeed elevate Finally, although we have shown that upregulation of
cAMP and activate PKA, this pathway is not needed to
Arg I is necessary and sufficient to overcome inhibition
reach the threshold of activation of CREB required for
by MAG, the fact that CREB regulates numerous genes
survival; activation of the Erk pathway is sufficient, be-
suggests that it is possible and highly likely that othercause a lower threshold of activated CREB is required.
upregulated proteins can also affect regeneration. TheThis hypothesis in turn implies that different genes are
important point here is that there are likely to be otherturned on depending on the strength and duration of
parallel pathways that are activated that can also over-the CREB signal. Although Arg I has been shown to be
come inhibition and promote regeneration, which wouldan antiapoptotic agent (Esch et al., 1998), this function
broaden the spectrum of possible targets for therapeuticis not a consequence of neurotrophin signaling. It re-
intervention. In summary, we have identified CREB asmains to be seen, however, whether or not blocking the
a central player in the ability of cAMP to overcome inhibi-synthesis of polyamines has any effect on the survival
tion by MAG, and in promoting spinal axon regenerationeffects of neurotrophins.
in vivo, hence placing it in a pivotal position as a thera-Alternatively, it is possible that at the molecular level
peutic target to encourage regeneration in vivo.CREB regulation is the same but that the cellular and
extracellular milieu dictate how the neuron can respond.
For example, to achieve regeneration, CREB must acti-
Experimental Procedures
vate a growth program and overcome inhibition. Like-
wise, for processes such as memory and learning, syn- Neurite Outgrowth Assay
apses must be strengthened by process outgrowth For myelin membranes (Norton and Poduslo, 1973), wells of an
eight-chamber tissue culture slide (Lab-Tek) were coated with 16.6(Castellucci et al., 1970; Kupfermann et al., 1970). Mech-
g/ml poly-l-lysine at room temperature for 1 hr. Rat CNS myelinanistically, there are many similarities between what is
at 0.5–1.0 g total protein/well was dried overnight onto the coatedrequired structurally to encourage growth during regen-
wells and used as a substrate (Mukhopadhyay et al., 1994; Shen eteration and growth associated with plasticity. Indeed,
al., 1998). Monolayers of control and MAG-expressing CHO cellsfor the model of learning and memory long-term potenti-
were grown to confluency in individual chambers of an 8-well tissue
ation (LTP), many of the steps shown to be involved are culture slide (Lab-Tek). Where indicated, isolated cerebellar (P3–P7)
similar to what we describe here—cAMP/PKA, CREB, and DRG (P5–P8) neurons in Sato (200 nM progesterone, 224 nM
and BDNF are involved in both (see Kandel, 2001). In selenium, 4 g/ml insulin, 0.35 mg/ml BSA, 0.4 g/ml L-thyroxine,
addition, polyamine synthesis has been shown to play 0.34 g/ml tri-iodo-thyronine) were plated on poly-l-lysine and
primed overnight with either BDNF or NGF (200 ng/ml) (Sigma), ina role in the modulation of synaptic transmission (Aizen-
the presence or absence of either PKA inhibitor KT-5720 (200 nM),man et al., 2002).
PI3K inhibitor LY294002 (20 M), MEK inhibitor U0126 (5 M), orThere are at least two other mechanisms that can
CaMK inhibitor KN62 (10 M) (Calbiochem) before being transferredcontribute to the specificity of the response to CREB
to myelin or the CHO cells. The neurite outgrowth assay was carried
activation. First, in addition to phosphorylation at out as described previously (Mukhopadhyay et al., 1994) with the
Ser133, CREB can also be phosphorylated at Ser129, following modifications: 5  104 neurons were plated onto immobi-
-142, and -143 (Kornhauser et al., 2002). Different combi- lized myelin, and 2 104 neurons were used for the CHO cell mono-
nations of phosphorylation of these serines appear to layers. Where indicated, 5 mM DFMO and 1 mM db-cAMP with
or without 200 nM PKA inhibitor KT-5720, 20 M PI3K inhibitoroccur in response to different stimuli. This in turn may
LY294002, 5 M MEK inhibitor U0126, or 10 M CaMK inhibitorinfluence which coactivators or corepressors associate
KN62 were added to the cultures. After 16–18 hr, the cultures werewith CREB, which then leads to differential transcription.
fixed and immunostained for GAP43 as described previously (Muk-In the study presented here, we have only assessed
hopadhyay et al., 1994). The length of the longest neurite or thethe phosphorylation state of Ser133. The extent of its
total process length for each GAP-43-positive neuron for the first
phosphorylation is consistent with the threshold of acti- 200 neurons encountered when scanning the slide in a systematic
vation of CREB that we propose is necessary to over- manner was determined using an Oncor image analysis program.
come inhibition. It is possible, however, that one or more The percentage change was the same regardless of the method
of analysis.of the other serines known to contribute to the activation
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Recombinant Adenovirus Surgical Procedures
Female Long-Evans rats, 8 weeks old, were used; nine animals wereRecombinant adenovirus containing A-CREB was constructed by
subcloning CREB dominant-negative cDNA (provided by Dr. Charles injected with a type 3 recombinant adenovirus expressing VP-CREB
(Barco et al., 2002), and six were injected with control adenovirus,Vinson, National Cancer Institute) into pTRACK CMV and then in-
serting it by homologous recombination into pAdeasy-1 (He et al., expressing only GFP under a CMV promoter. DRG injections were
carried out as described previously. Briefly, the L3–L4 vertebrae1998). The viral preparation and purification was carried out as de-
scribed (He et al., 1998). Recombinant adenovirus VP16-CREB, fu- were exposed, and the left L4 DRG was then unilaterally exposed
by a partial laminectomy. Injection of the virus was carried out withsion protein between HSV VP16 (aa 363 to 490), and CREB (aas 88
to 341) (Barco et al., 2002) was constructed using the Tet-Off system a stereotaxic frame (David Kopf Instruments), using a micropipette
with an OD of 50 m, inserted to a depth of 20 m (Qiu et al.,from Clontech. Cerebellar or DRG neurons were isolated and plated
on the poly-l-lysine-coated 24-well plates. Neurons were infected 2002). Two microliters of the viral solution (2 1011 pfu, VP16-CREB
Ad; 3  1010 pfu, control Ad) was infused at a rate of 0.5 l/min,with adenovirus at a final concentration of 1010 PFU/ml (or MOI 
100) and maintained in virus-containing media for 1 hr, after which and the micropipette was left in place for a further 2 min before
removal, to facilitate diffusion of the virus within the DRG and pre-they were washed and the media replaced. After overnight culture
to allow expression of the transgene, neurons were either primed vent “leakage.” The overlying muscle was then sutured back in
place, and the skin was closed using wound clips. Four days later,with neurotrophins or transferred directly to monolayers of CHO
cells and incubated as described above. Neurite length was mea- a dorsal column lesion was carried out as described previously (Qiu
et al., 2002), at T6–T7 in seven of the constitutively active CREB-sured only from those neurons that were both GAP43 and GFP
positive; in this way only infected neurons were assessed. Alterna- expressing animals and five of the control virus-infected animals.
After 24 days, they were transganglionically traced with a 4 l injec-tively, infected neurons were lysed in sample buffer and subjected
to Western blot analysis. tion of 1% biotinylated cholera toxin B subunit (List Biologicals),
delivered by Hamilton syringe, into the left sciatic nerve (10 mm
proximal to the Tibial/Peroneal nerve bifurcation), which was then
Western Blot Analysis crushed to facilitate penetration of the tracer into the axons. Four
Neurons were starved for 1 hr in DMEM and then incubated for days later, under deep anesthesia, animals were transcardially per-
different times with combinations of BDNF (200 ng/ml), NGF (200 fused with 300 ml of PBS, containing 1000 U/l of heparin (Sigma-
ng/ml), db-cAMP (1–2 mM), PKA inhibitors H89 (5 M) and KT-2750 Aldrich) and 250 ml of ice-cold 4% paraformaldehyde, in PBS. The
(200 nM), PI3K inhibitor LY294002 (20 M), MEK inhibitors PD98059 thoracic spinal cord was then removed and postfixed in 4% para-
(50 M) and U0126 (5 M), or CaMK inhibitor KN62 (10 M) (Calbio- formaldehyde for 50 min, before being cryoprotected in 10% su-
chem) as indicated. Neurons were then washed with PBS and lysed crose solution (in PBS) for 2 hr and 20% sucrose (in PBS) overnight.
in boiled sample buffer (62.5 mM Tris-HCl [pH 6.8] and 2% SDS), Samples were then placed in OCT embedding media, appropriately
which included phosphatase inhibitors, 20 mM NaF, 1 mM Na3VO4, aligned, and frozen for sectioning using dry ice.
and 10 mM -glycerophosphate (Sigma). Samples were run through Two animals from each group were transcardially perfused 4 days
DNA shredders (Qiagen), and protein was measured by a Lowry- after injection of the viral solution to evaluate expression of the virus
based protein assay (BioRad). Fifty micrograms of protein for detec- at the time of the dorsal column lesion in other animals. The lumbar
tion of CREB and 20 g of protein for detection of Arg I were loaded spinal cord and dorsal nerve roots were then removed and prepared
and separated by 10% SDS-PAGE. After electrophoresis, gels were for sectioning according to the above method.
transferred to PVDF membranes (NEN) and probed with either a
phospho-CREB (Ser133) antibody (Cell Signaling), a CREB antibody
Immunofluorescent Staining(Cell Signaling), an actin antibody (Sigma), or an Arg I antibody
Thoracic spinal cord samples were cut into 20 m thick longitudinal(kindly provided by Dr. Rajiv R. Ratan, Harvard Medical School)
sections using a Jung Frigocut 2800N cryostat, collected onto Fisherovernight at 4	C. Blots were incubated with an anti-rabbit IgG-HRP
Brand Superfrost Plus slides. Briefly, sections were washed in PBSsecondary antibody (1:5000) for 1 hr, and detection was performed
and then incubated in blocking media (PBS with 2.5% BSA, 0.5%using ECL (Amersham). Some blots were later stripped with stripping
Triton X-100, and 2% normal goat serum) for 1 hr. Slides werebuffer (0.2 M glycine [pH 2.2], 1% Tween-20, and 0.1% SDS) for
then incubated with goat -Choleragenoid (1:2000; List Biologicals),1 hr at room temperature and reprobed as indicated. The expression
2.5% BSA, and 2% Triton X-100, overnight at 4	C. They were thenlevels of proteins were quantitated by a FluorImage system.
washed and blocked with 2% normal donkey serum for 1 hr. Sec-
tions were then incubated either with biotinylated donkey -goat
Isolation of Neurons from Transgenic Mice (1:200; Santa Cruz Biotechnology) alone or in combination with
Bitransgenic mice were generated by crossing pCaMKII-tTA mice mouse -III tubulin (1:1000; Covance) in PBS containing 2.5% BSA
and tetO-VP16-CREB transgenics (Barco et al., 2002). For all experi- and 2% Triton X-100, for 2 hr. They were then washed, before being
ments, Dox was administrated at 40 mg/kg of food and removed 1 incubated with Fluorescein-conjugated Streptavidin (1:200; Amer-
week before experimentation. Hippocampal and DRG neurons were sham), and either Texas red-conjugated sheep -mouse (1:200;
dissociated and plated onto a tissue culture dish and incubated Amersham) or mouse -Glial Fibrillary Acidic Protein (Cy-3 Conju-
overnight. Unadhered debris was gently washed off by PBS, and gate; 1:400; Sigma) in PBS containing 2.5% BSA and 2% Triton
the neurons were transferred to monolayers of CHO cells and incu- X-100, for 1 hr. Immunofluorescence was visualized under a Nikon
bated as described above. Neurite length was measured only from E400 microscope, and images were captured with a Hamamatsu
those neurons that were both GAP43 and GFP positive; in this way C4742-95 camera, using Simple PCI. Once the images were mon-
only infected neurons were assessed. Alternatively, hippocampus taged, an image of a grid, obtained from a hemocytometer under
and DRG were homogenized in sample buffer and prepared for exactly the same imaging conditions, was then superimposed on the
Western blot analysis. reconstructed picture and was used for obtaining measurements.
MeasurementsImmunostaining of Neurons
The section with the furthest penetration of CTb-labeled axons intoIsolated cerebellar neurons (5  104) were plated onto immobilized
the lesion site was selected for each animal and used for the mea-myelin or poly-l-lysine-coated chambers of an 8-well tissue culture
surements.slide and incubated overnight. After 1 hr starvation with DMEM,
either BDNF (200 ng/ml) or db-cAMP (1 mM) was added to the
culture and incubated for 30 min. The cells were then fixed and Acknowledgments
double stained with a rabbit anti phospho-CREB antibody (Cell Sig-
naling) and a mouse anti-NF200 antibody (Sigma) overnight at 4	C, We thank Melissa Hilaire and Kambiz Etesami for their outstanding
technical support; and Dr. Lloyd Williams for his help with the imagefollowed by a 1 hr incubation with an anti-rabbit IgG-Texas Red and
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